Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$310K Buy
+4,761
New +$285K 0.02% 426
2025
Q1
Sell
-4,362
Closed -$314K 516
2024
Q4
$314K Sell
4,362
-25
-0.6% -$1.95K 0.02% 394
2024
Q3
$357K Buy
4,387
+107
+3% +$8.56K 0.02% 377
2024
Q2
$318K Buy
4,280
+409
+11% +$30.7K 0.02% 371
2024
Q1
$302K Buy
3,871
+147
+4% +$10.9K 0.02% 369
2023
Q4
$266K Buy
+3,724
New +$259K 0.02% 369

Other funds holding HOLX

Graypoint LLC's HOLX Position: Q2 2025 in Review

Graypoint LLC opened a new position in Hologic (HOLX) in Q2 2025: 4,761 shares worth $310K. The stake represents 0.02% of the portfolio and ranks #426 among its holdings. This is a return to the name: Graypoint LLC previously reported a position in HOLX as recently as Q4 2024.

Graypoint LLC first reported a position in HOLX in Q4 2023 and has held it in 6 quarters since. The position peaked at $357K in Q3 2024. 692 funds tracked by Wall St. Rank hold HOLX as of Q2 2025.

  • Graypoint LLC held 4,761 shares of Hologic worth $310K as of Q2 2025.
  • Hologic was a new Graypoint LLC position in Q2 2025.
  • Hologic made up 0.02% of Graypoint LLC's portfolio in Q2 2025, its #426 holding.
  • Graypoint LLC first reported a position in Hologic in Q4 2023 and has held it in 6 quarters since.
  • Graypoint LLC's Hologic position peaked at $357K in Q3 2024.
  • 692 funds tracked by Wall St. Rank held Hologic as of Q2 2025.

Based on Graypoint LLC's 13F filing for Q2 2025, filed 15 Jul 2025.